Sponsor or institution
Clinical trials and research at Can-Fite BioPharma
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Can-Fite BioPharma that are recruiting, at sites in 9 countries (most in Israel (2), Bosnia and Herzegovina (1), Bulgaria (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 9Countries
All recruiting trials (2)
-
Namodenoson treatment for advanced pancreatic cancer
This study is testing a new oral medication called namodenoson to see if it can help people with advanced pancreatic cancer feel better and improve their condition.
-
Treatment of advanced liver cancer with namodenoson in patients with severe cirrhosis
This study is testing if a new drug called namodenoson can help people with advanced liver cancer and severe cirrhosis feel better and live longer compared to a placebo.
Quick answers
How many clinical trials run by Can-Fite BioPharma are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Israel (2 trials), Bosnia and Herzegovina (1 trial), Bulgaria (1 trial), Moldova (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.